VANCOUVER, BC, January 25, 2022 – REVITALIST LIFESTYLE AND WELLNESS LTD. (“Revitalist” or the “Company”) (CSE: CALM) (OTC: RVLWF) (FSE: 4DO) is pleased to announce the appointment of Dr. Denise Hopkins-Chadwick, PhD RN, Retired US Army Colonel, as Vice President of Research and Development (“R&D”).
Kathryn Walker, CEO, commented, “On behalf of the team at Revitalist, I am very excited to welcome Denise to the company. As Revitalist continues to grow, we are pleased to have someone of Denise’s caliber and experience lead R&D in or organization. Denise will be pivotal in achieving our ambitious funding goals and securing grants to further the mission of Revitalist.”
Denise Hopkins-Chadwick received her PhD from the Ohio State University in Columbus, Ohio and has over 35 years of experience writing grants and working with patients, research participants, families, and faculty. Denise is a 30-year active-duty veteran Commissioned Officer in the Nurse Corps with clinical background experience spanning adults to neonatal ICUs, Emergency departments and patient transport. She serves on multiple boards including the Military Medicine Journal and the Tri-Service Nursing Research Interest Group: Women’s Health. Throughout her career, she has received dozens of awards in healthcare research and has secured research funding of over $50 million. She is Co-Inventor of the Precision Health Insight Tool which integrates data from multiple sources including behavioral health and pharmaceuticals into a unified system. Denise is also the founder of HC Research Associates, a company providing professional R&D as well as academic activities.
Dr. Denise Hopkins-Chadwick, commented, “I could not be happier about joining Revitalist and look forward to working with the team as we embark on the research and development of transformative programs which have a positive impact on patients and their families.”
ABOUT REVITALIST LIFESTYLE AND WELLNESS Ltd.
Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTC: RVLWF) (FSE: 4DO) is a publicly traded company, headquartered in Knoxville, Tennessee, with clinics operating across the United States and expanding. Revitalist is dedicated to empowering individuals toward an improved quality of well-being through a combination of comprehensive care and future-centric treatments provided by medical professionals, mental health experts, and chronic pain specialists. Since opening their first clinic in 2018, Revitalist has provided thousands of infusions for patients suffering from treatment-resistant conditions. Additionally, Revitalist offers a number of lifestyle optimization services and vitamin infusions that can bring anyone closer to total wellness. For additional information and to be added to the Company’s mailing list, please click here.
On Behalf of the Board
Chief Executive Officer
For further information please contact:
Revitalist Lifestyle and Wellness Ltd.
Tel: (865) 585-8414
Forward Looking Statements
This news release contains forward-looking statements and information within the meaning of applicable securities legislation. Often, but not always, forward-looking statements and information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward looking statements or information involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Revitalist to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements or information contained in this news release.
Risks, uncertainties, and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.